INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

20,939 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$283
1 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

Page 400 of 524
← PrevNext →
20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL
$17K
62 sh
Jan 26, 2026
Jan 27, 2026
traded Jan 26, 2026
+1d
SEC Form 4

Evidence

20
HK
Hogan Catherine KiernanChief Operating Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$30K
107 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

20
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$145K
514 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

18
DM
Dube Eric MDirector, CHIEF EXECUTIVE OFFICER
TVTXTravere Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$244K
8,135 sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

15
SJ
Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER
LTHLife Time Group Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$360K
12.1K sh
Jan 23, 2026Jan 27, 2026
traded Jan 23, 2026
+4dSEC Form 4

Evidence

13
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$47K
168 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

13
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$8,904
32 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

13
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$567
2 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

13
CL
Clifford Katherine LeeChief Leadership & HR Officer
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$20K
71 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$270K
1,987 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$265K
1,913 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$270K
1,988 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$364K
2,663 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$265K
1,914 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

9
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$364K
2,664 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

6
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$131K
950 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

6
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$131K
951 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$13K
100 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
Farquhar ScottDirector, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$6,652
50 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

3
CM
Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner
TEAMAtlassian Corp
Open-market sale · 10b5-1 plan
SELL$6,652
50 sh
Jan 26, 2026Jan 27, 2026
traded Jan 26, 2026
+1dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$2.81M
7,200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$2.00M
19.1K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$1.99M
5,128 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$1.00M
9,525 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$3.32M
8,500 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

35
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$1.00M
9,525 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

33
TA
Tpg Gp A, Llc10% Owner
SIONSionna Therapeutics, Inc.
Open-market sale
SELL$10.00M
250.0K sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

33
SJ
Sibold William JohnDirector, President and CEO
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$777K
1,577 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$864K
2,200 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
WA
Wilson Kelli AnnEVP Chief Banking Officer
HFWAHERITAGE FINANCIAL CORP /WA/
Open-market sale
SELL$50K
1,900 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

32
SC
Schwab-Pomerantz CarolynDirector
SCHWSCHWAB CHARLES CORP
Open-market sale
SELL$500K
4,765 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$511K
1,295 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

32
BH
Bhatia Manish HEVP, Global Operations
MUMICRON TECHNOLOGY INC
Open-market sale
SELL$911K
2,300 sh
Jan 22, 2026Jan 26, 2026
traded Jan 22, 2026
+4dSEC Form 4

Evidence

30
TR
Taub RebeccaDirector
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale
SELL$319K
647 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

29
BH
Beckwith Van H.EVP, Secretary and CLO
HALHALLIBURTON CO
Open-market sale · 10b5-1 plan
SELL$1.90M
54.3K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

27
OP
O'Day Daniel PatrickDirector, Chairman & CEO
GILDGILEAD SCIENCES, INC.
Open-market sale · 10b5-1 plan
SELL$15.61M
115.6K sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence

25
HC
Huntsman CaroleChief Commercial Officer
MDGLMADRIGAL PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$282K
570 sh
Jan 26, 2026Jan 26, 2026
traded Jan 26, 2026
+0dSEC Form 4

Evidence

23
UJ
Unruch JoelGeneral Counsel/Corp Secretary
ACNAccenture plc
Open-market sale · 10b5-1 plan
SELL$172K
610 sh
Jan 23, 2026Jan 26, 2026
traded Jan 23, 2026
+3dSEC Form 4

Evidence